Latest Announcements
Ladenburg Thalmann acts as Lead Bookrunner for Eagle Point Income Company, Inc. on its Term Preferred Offering of $28 Million
Ladenburg Thalmann served as Lead Bookrunner for this offering. Since 2017, Ladenburg has led 52 fixed income transactions for BDC/Investment Companies raising over $2.4 Billion. Overall, Ladenburg has...
Ladenburg Thalmann Acts as Co-Manager for Harrow in its $60.0 Million Public Offering
Transaction Information Harrow Health, Inc. (NASDAQ: HROW) priced an underwritten registered public offering of 3,380,282 shares of its common stock at the public offering price of $17.75 per share. The...
Ladenburg Thalmann Acts as Sole Book-Running Manager for Kiora Pharmaceuticals, Inc. in its $6.3 Million Underwritten Public Offering
Transaction Information Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) announced the closing of an underwritten public offering for gross proceeds of approximately $6.3 million, which includes the full exercise of...
Ladenburg Thalmann Acts as Sole Book-Running Manager for Coeptis Therapeutics in its $3.5 Million Underwritten Offering
Transaction Information Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) announced the closing of an underwritten offering for gross proceeds of approximately $3.5 million to a single healthcare focused...
Ladenburg Thalmann Acts as Lead Manager for Axsome Therapeutics in its $225 Million Public Offering
Transaction Information Axsome Therapeutics, Inc. (NASDAQ: AXSM) announced the closing of its previously announced underwritten public offering of 3,000,000 shares of its common stock at the public offering...
Ladenburg Acts as Exclusive Placement Agent in a $3.32 Million Registered Direct Offering for Biodexa Pharmaceuticals PLC
Transaction Information Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), announced the closing of a registered direct offering of 22,135,922 American Depositary Shares ("ADS") at a price of $0.15 per ADS for gross...
Ladenburg Acts as Exclusive Placement Agent in $6 Million Registered Direct and Private Placement Offerings for Palisade Bio, Inc.
Offering Priced Above Market Under Nasdaq Rules Transaction Information Palisade Bio, Inc. (Nasdaq: PALI) announced that it has entered into definitive agreements with institutional investors to raise $6...
Ladenburg Acts as Sole Book-Running Manager in $12.4 Million Offering for Windtree Therapeutics, Inc.
Transaction Information Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced the closing of its underwritten public offering for gross proceeds of $12.4 million. The Company issued 4,238,906 shares of...
Ladenburg Acts as Exclusive Placement Agent in $3 Million Private Placement for NovaBay Pharmaceuticals, Inc.
Transaction Information NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announced it entered into a securities purchase agreement with institutional accredited investors ("Purchasers") in connection with a...
Ladenburg Acts as Sole Book-Running Manager in $2.55 Million Offering for Intelligent Bio Solutions Inc.
Transaction Information Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the "Company") announced the closing of its previously announced underwritten public offering of 654,990 shares of common stock and warrants...
Ladenburg Acts as Exclusive Placement Agent in $8 Million Offering for Ra Medical Systems, Inc.
Transaction Information Ra Medical Systems, Inc. (NYSEAmerican: RMED) announced that it has closed its previously announced private placement, which generated $8 million in gross proceeds. The Company...
Ladenburg Acts as Exclusive Placement Agent in $6 Million Offering for Midatech Pharma PLC
Transaction Information Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP) announced that it has raised $6.0 million of gross proceeds from U.S. institutional investors in a Private Placement offering. The offering...